Research

Mixed

Body composition assessment (quantifying fat-free mass, fat mass, and visceral adipose tissue) provides a more accurate assessment of cardiometabolic disease risk than Body Mass Index (BMI) alone, particularly for identifying 'normal weight obesity' and sarcopenic obesity.

Stop relying solely on the scale. If you are maintaining a 'normal' BMI but feel weak or have high blood sugar, ask for a body composition assessment (like DXA or BIA). This will reveal if you have 'normal weight obesity' (high fat, low muscle) or sarcopenic obesity (high fat, low muscle), which are high-risk conditions that BMI misses. Prioritize resistance training and protein intake to build muscle, as this is the most effective way to lower metabolic risk when BMI is misleading.

GoodQualifiesHIGH confidence
Obesity and low muscle mass are major public health concerns... Beyond body mass index, body composition metrics including skeletal muscle, fat mass, and visceral adipose tissue offer deeper insights into nutrition and disease risk.
Jonathan P. Bennett et al. · Journal of Obesity & Metabolic Syndrome · 2025

Why this rating

The paper is a comprehensive review citing numerous epidemiological studies and consensus guidelines.

Source

The Critical Role of Body Composition Assessment in Advancing Research and Clinical Health Risk Assessment across the Lifespan

Jonathan P. Bennett et al. · Journal of Obesity & Metabolic Syndrome · 2025

DOI 10.7570/jomes25010

narrative_reviewCited 28×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →